A number of serious questions need to be put to the CPH board. For example:
If CPH is effectively taking over RLH (but in reverse), why are CPH management not running/leading the new organisation? This makes no sense.
Also, why would CPH propose such an unfavourable deal when they’ve just listed on the OTC market and have gone on and on about the potential of their proposed acquisition of halucenex? Did they suddenly lose faith in their ability to deliver on all the bold/outrageous claims they recently made about this and the OTC listing?
Why are the RLH and CPH share prices both plummeting on the news? Have all shareholders smelt a stinky rat?
Something is seriously wrong here IMHO and CPH holders should demand answers. Don’t let paid company reps (that are already on this thread) bully you around.
